Drug Shortage Report for VITAMIN K1

Last updated on 2020-05-12 History
Report ID 113624
Drug Identification Number 00781878
Brand name VITAMIN K1 INJ 1MG/0.5ML USP
Common or Proper name VITAMIN K1 INJ 2MG/0.5 ML
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) VITAMIN K1
Strength(s) 2MG
Dosage form(s) EMULSION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10MG/ML
ATC code B02BA
ATC description VITAMIN K AND OTHER HEMOSTATICS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-05-01
Estimated end date 2020-05-08
Actual end date 2020-05-07
Shortage status Resolved
Updated date 2020-05-12
Company comments Release delay at manufacturing site. Product had been placed on allocation at 50% of historical usage. Alternative product 9110 VITAMIN K1 INJ 10MG/ML remains available and is on protective allocation at 125% of historical usage.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-05-12 French Compare
v4 2020-05-12 English Compare
v3 2020-05-02 English Compare
v2 2020-05-01 French Compare
v1 2020-05-01 English Compare

Showing 1 to 5 of 5